PET imaging of meningioma after radionuclide therapy. (IMAGE)

Society of Nuclear Medicine and Molecular Imaging

PET imaging of meningioma after radionuclide therapy.

Caption

Transaxial slices of baseline positron emission tomography (PET) and fused PET/magnetic resonance imaging (MRI; left) demonstrate a somatostatin receptor-expressing meningioma in the left cavernous sinus (white and black arrows). After four cycles of peptide receptor radionuclide therapy (PRRT), a complete remission according to the Response Assessment in Neuro-Oncology as well as PET criteria was recorded (right). Scale bars denote standardized uptake values.

Credit

Image created by A Amerein, M Kircher, C Lapa, et al., University of Augsburg, Augsburg, Germany.

Usage Restrictions

Please give appropriate credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.